Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1-Reference-Cited by-同舟云学术

Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1

Published:2015-07-15 Issue:1 Volume:13 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Michelhaugh Sharon K,Guastella Anthony R,Varadarajan Kaushik,Klinger Neil V,Parajuli Prahlad,Ahmad Aamir,Sethi Seema,Aboukameel Amro,Kiousis Sam,Zitron Ian M,Ebrahim Salah A,Polin Lisa A,Sarkar Fazlul H,Bollig-Fischer Aliccia,Mittal Sandeep

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-015-0596-8

Reference57 articles.

1. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 14(Suppl 5):v1–v49. doi: 10.1093/neuonc/nos218

2. Mawrin C, Perry A (2010) Pathological classification and molecular genetics of meningiomas. J Neurooncol 99(3):379–391. doi: 10.1007/s11060-010-0342-2

3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO classification of tumours of the central nervous system, 2007th edn. IARC, Lyon

4. Alexiou GA, Gogou P, Markoula S, Kyritsis AP (2010) Management of meningiomas. Clin Neurol Neurosurg 112(3):177–182. doi: 10.1016/j.clineuro.2009.12.011

5. Moazzam AA, Wagle N, Zada G (2013) Recent developments in chemotherapy for meningiomas: a review. Neurosurg Focus 35(6):E18. doi: 10.3171/2013.10.FOCUS13341

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis;Cancers;2023-11-09

2. Meningioma animal models: a systematic review and meta-analysis;Journal of Translational Medicine;2023-10-28

3. Patient-derived ex vivo cell culture growth dynamics predict recurrence probability in patients with atypical and anaplastic meningiomas;2023-07-26

4. Modeling Meningiomas;Neurosurgery Clinics of North America;2023-07

5. Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas;Acta Neuropathologica;2023-04-24